NVAX
Price:
$9.13
Market Cap:
$1.50B
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The c...[Read more]
Industry
Biotechnology
IPO Date
1995-12-05
Stock Exchange
NASDAQ
Ticker
NVAX
According to Novavax, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.30. This represents a change of 262.39% compared to the average of -4.50 of the last 4 quarters.
The mean historical PE Ratio of Novavax, Inc. over the last ten years is -3.49. The current -16.30 PE Ratio has changed 46.61% with respect to the historical average. Over the past ten years (40 quarters), NVAX's PE Ratio was at its highest in in the December 2025 quarter at 15.27. The PE Ratio was at its lowest in in the June 2020 quarter at -69.46.
Average
-3.49
Median
-1.60
Minimum
-15.01
Maximum
2.47
Discovering the peaks and valleys of Novavax, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.94%
Maximum Annual PE Ratio = 2.47
Minimum Annual Increase = -137.80%
Minimum Annual PE Ratio = -15.01
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 2.47 | -137.80% |
| 2024 | -6.54 | 636.73% |
| 2023 | -0.89 | -27.33% |
| 2022 | -1.22 | -80.00% |
| 2021 | -6.10 | -59.33% |
| 2020 | -15.01 | 1.94% |
| 2019 | -0.74 | -79.99% |
| 2018 | -3.68 | 86.56% |
| 2017 | -1.97 | 62.04% |
| 2016 | -1.22 | -91.31% |
The current PE Ratio of Novavax, Inc. (NVAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.65
5-year avg
-2.46
10-year avg
-3.49
Novavax, Inc.’s PE Ratio is less than CureVac N.V. (7.10), less than Zenas BioPharma, Inc. (-2.17), greater than Terns Pharmaceuticals, Inc. (-51.41), less than Upstream Bio, Inc. (-2.15), less than Wave Life Sciences Ltd. (-5.81), greater than Trevi Therapeutics, Inc. (-53.41), less than Intellia Therapeutics, Inc. (-4.43), less than Precigen, Inc. (-3.76), less than Nektar Therapeutics (-7.24), less than ORIC Pharmaceuticals, Inc. (-5.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| 7.10 | $1.05B | |
| -2.17 | $883.04M | |
| -51.41 | $4.77B | |
| -2.15 | $340.12M | |
| -5.81 | $1.19B | |
| -53.41 | $2.44B | |
| -4.43 | $1.76B | |
| -3.76 | $1.45B | |
| -7.24 | $1.19B | |
| -5.90 | $878.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novavax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Novavax, Inc.'s PE Ratio?
How is the PE Ratio calculated for Novavax, Inc. (NVAX)?
What is the highest PE Ratio for Novavax, Inc. (NVAX)?
What is the 3-year average PE Ratio for Novavax, Inc. (NVAX)?
What is the 5-year average PE Ratio for Novavax, Inc. (NVAX)?
How does the current PE Ratio for Novavax, Inc. (NVAX) compare to its historical average?